TRANSPLANTATION FOR POLYCYSTIC KIDNEY DISEASE
- 1 July 1983
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 36 (1) , 54-59
- https://doi.org/10.1097/00007890-198307000-00012
Abstract
During the 4-yr period from June 1977-May 1981, 108 patients with polycystic kidney disease and 2440 nonpolycystic patients received cadaver renal allografts in the Southeastern Organ Procurement Foundation (SEOPF) Prospective Study. There were no significant differences between groups with and without polycystic disease in terms of recipient blood group, history of splenectomy, or preformed antibody status. As a group, transplanted polycystic patients underwent native nephrectomy more often, had a better HLA match, received less antilymphocyte serum (ALS), and were slightly older than nonpolycystic patients. Although proportionately fewer polycystic patients received pretransplant transfusions than nonpolycystic patients (P = 0.002), transfusion was associated with a significant increase in graft survival in the polycystic group (P < 0.05), as well as in the nonpolycystic group (P < 0.0001). Gene frequency analysis showed no HLA-A, or -B antigen linkage with polycystic disease. No significant differences existed between the polycystic and nonpolycystic groups in terms of overall graft and patient survival. However, transplanted polycystic patients died more frequently from bacterial sepsis (P < 0.05), especially from gram-positive organisms (P = 0.01). Pretransplant bilateral nephrectomy did not affect the incidence of sepsis. However, following graft failure, patients with bilateral native nephrectomy had a greater incidence of severe anemia (50% vs. 39%) and death (58% vs. 25%; P < 0.05) than those with unilateral nephrectomy or no nephrectomy. Treatment with ALS did not significantly improve graft survival in those with polycystic disease. A strong positive correlation was found between patient death and treatment with ALS only in the polycystic group (P < 0.01). Use of pretransplant bilateral native nephrectomy and posttransplant ALS should be judicious in the polycystic patient because they may be associated with increased morbidity and mortality.This publication has 1 reference indexed in Scilit:
- Management of End Stage Polycystic Kidney Disease with Renal TransplantationJournal of Urology, 1981